top of page

Gang LI



Gang Li is a full professor in the Department of Orthopedics and Traumatology, Faculty of Medicine , The Chinese University of Hong Kong. He received MBBS at the Fourth Military Medical University, Xian, China (1991) and D. Phil. at the University of Oxford School of Medicine, England, UK (1998). The focuses of his research are on biological mechanisms of distraction osteogenesis, stem cell biology, cell therapy applications in musculoskeletal tissue engineering. He has published more than 290 peer-reviewed SCI articles with citations over 12,000 and H index 67 (Google scholar 05-2022); 15 book chapters, edited 3 books on tissue engineering, bone biology, distraction histogenesis and Ilizarov techniques. He is a council member of Chinese Orthopaedic Research Society; Chinese ORS Representative to International Combined Orthopaedic Research Societies (ICORS); Member of International Committee, American Orthopaedic Research Society (ORS); Vice Chairman, Branch of Regenerative Biomaterials, Chinese Association of Materials; Member-at-Large (Global position), Tissue Engineering and Regenerative Medicine Society (TERMIS) Asia Pacific (AP); Chairman of ILLRS and ASAMI China Branch. He is executive associate editor for Journal of Orthopaedic Translation (IF: 5.19); editor for Calcified Tissue International, Bone and Joint Research, Bone and Journal of Orthopaedic Research. He holds honorary or visiting Professorship at many prestigious universities such as Monash University, Australia; South-East University Medical School, China; The Airforce Medical University, China; etc. His work received serval awards including 1st Class Award in Science Advances, Ministry of Science and Technology, PR China; 1st Class Research Award in Science and Technology, Ministry of Education, China; 2nd Class Award in Medical Science and Technology, China Medical Association. He is elected as fellow of International Combined Orthopaedic Research Societies (FIORS) in 2016 and fellow of American Orthopaedic Research Society (FORS) in 2020.

Get in Touch


  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page